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Peptides generated by the thymus-specific proteasome and presented by MHC class I molecules on the surface of cortical thymic epithelial
cells play an important role in the positive selection of thymocytes. The thymoproteasome uniquely contains the b5 t subunit. In this short
communication, the Overkleeft group shows by using a panel of activity-based probes (APB), affinity purification, and active-site determina-
tion by LC-MS3 that the b5 t is indeed an active thymo-proteasome subunit. Interestingly, ABP’s with a Thr at P2 react with b5 t, suggesting
a substrate preference different from the b5 and b5i subunits.
Marine Macrolide Captures Actins Attention
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Many forms of marine macrolides exhibit toxicity toward the actin cytoskeleton and thus are promising templates from which to design anti-
cancer and antimicrobial therapeutics. Lobophorolide is amarinemacrolide derived from the common tropical seaweed Lobophora variegata
that disrupts the actin cytoskeleton using a mechanism that is different from many other macrolides. Blain et al. now show that it stabilizes
a polymerization-deficient actin dimer in which two lobophorolide molecules cooperate to form a dimerization interface that is composed
entirely of the small molecule. This binding mode holds important implications for development of actin-targeting drugs and the evolution
of macrolide biosynthetic enzymes.
Fighting Malaria with Small Molecule Inhibitors and Active Site Probes
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Malaria remains one of the most devastating infectious diseases, causing close to a million deaths
peryear. Theemergenceofdrug resistance toall affordabledrugscontinues tobe themainhurdle to
treat this disease. It is therefore urgent to identify new drug targets to expand the portfolio of anti-
malaria drugs. In this work, Deu et al. describe the use of small molecule inhibitors and use activity-
basedprobes todemonstrate that inhibitionofdipeptidyl aminopeptidase1 impairsparasitegrowth
both in vitro and in amousemodel of malaria. Overall, the study validates this cysteine protease as
an antimalarial target and identifies several potentially valuable inhibitor scaffolds for this protease.
Metabolomic View of Microbial World
PAGE 820
Liebeke et al. now report comparison of quantitative metabolite levels of Staphylococcus aureus
grown in complex LB-Broth and inminimalmediumwith that of wild-typeS. aureus strain 8325 and
the isogenic eukaryotic-like protein serine/threonine kinase (DpknB) and phosphatase (Dstp) dele-
tion mutants. Detection of several remarkable differences, e.g., in nucleotide metabolism andespecially cell wall precursor metabolites, indicates a previously unreported importance of serine/threonine kinase/phosphatase on peptido-
glycan andwall teichoic acid biosynthesis. These findingsmay lead to new insights into the regulation of staphylococcal cell wall metabolism.
Brain Metabolomics of GDE1(/) Mice
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The function of glycerophosphodiesterase (GDE) enzymes in mammalian organisms is largely unknown. Here, Kopp et al. show, usingmouse
genetics and untargeted metabolomics, that GDE1 regulates a set of glycerophospho (GroP) metabolites in brain, including both known
(GroP-inositol) and novel (GroP-serine and GroP-glycerate) natural products. The metabolomic profiles also revealed that serine was signif-
icantly reduced in brains of GDE1-disrupted mice, thus designating GroPSer as a reservoir for free serine in the nervous system. Taken
together, these findings indicate that the mammalian ‘‘GroP-metabolome’’ is quite diverse in structure and function and designate GDE1
as one of its principal enzymatic regulators in vivo.
Hydroperoxoferric Intermediate in Cytochrome P450 Epoxidation
PAGE 841
Kells et al. present an X-ray structure of PimD both substrate-free and in complex with
4,5-deepoxypimaricin. PimD is a cytochrome P450 monooxygenase with native epoxidase
activity that is critical in the biosynthesis of the polyene macrolide antibiotic pimaricin. Epoxi-
dation by P450 typically includes formation of a charge-transfer complex between an oxoferryl
p-cation radical species (Compound I) and the olefin p-bond as the initial intermediate.
Evidence presented here suggest that epoxidation of 4,5-deepoxipimaricin proceeds via
a hydroperoxoferric intermediate (Compound 0). The oxygen atom of Compound 0 distal to
the heme iron may insert into the double bond of the substrate to make an epoxide ring.Chemistry & Biology 17, August 27, 2010 ª2010 Elsevier Ltd All rights reserved v
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Farha and Brown tackle the problem of understanding the mechanism of action of growth perturbing small molecules that have been discov-
ered in compound screening. Here, the authors probed the mode of action of uncharacterized inhibitors of the growth of Escherichia coliwith
careful investigations of the interactions with compounds of known biological activity. Specifically, they examined growth inhibition by
a collection of 200 novel antibacterial compounds when combined with a panel of 14 known antibiotics of diverse mechanism and chemical
class. The chemical-chemical interaction data provide a fingerprint of biological activity and testable hypotheses regarding themechanism of
action of novel bioactive molecules, which was used to determine the mode of action of an inhibitor of folate biosynthesis and a DNA gyrase
inhibitor and identify eight membrane-active compounds, found to be promiscuously synergistic with known bioactives.
From an Esterase to a Hydroxynitrile Lyasevi Chemistry & Biology 17, August 27, 2010 ª201PAGE 863
Proteins with similar structure can catalyze different chemical reactions. To learn how
enzymes catalyze reactions, evolve to catalyze new reactions, and create new enzymes
for synthesis, researchers engineer new types of catalytic activity into enzymes. The
closest structural relatives of SABP2, a plant esterase, are not other esterases, but
hydroxynitrile lyases (HNLs), which catalyze a different reaction. Previous structural and
mechanistic studies identified two amino acid differences in the active site of HNLs as
compared to esterases. Padhi et al. now show that making those two substitutions in
SABP2 switches its esterase activity to HNL activity.
Surfactin Synthetase Initiation Module
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The fatty acid moiety is a key structural element of nonribosomally assembled lipopep-
tide antibiotics, but little is known about the mechanism of lipid transfer during the initial
step of biosynthesis. In this study, Kraas et al. dissect the initiation condensation domainof the surfactin synthetase SrfAA and identify that it catalyzes amide bond formation between the CoA-activated fatty acid and the N-
terminal amino acid of surfactin. Biochemical and gene disruption studies of four fatty acyl coA ligases of Bacillus subtilis confirm the
suggestion that the activated fatty acids for surfactin biosynthesis are provided in trans by enzymes from biological pathways of the primary
metabolism.
Targeting Integral Membrane Proteins
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Membrane proteins are important pharmaceutical targets, but they pose challenges for fragment-based drug discovery. Here, Fru¨h et al.
present the first successful use of biophysical methods to screen for ligands to an integral membrane protein. The E. colimembrane protein
DsbB was solubilized in detergent micelles and lipid bilayer nanodiscs. DsbB was immobilized with retention of functionality and used to
screen 1,071 drug fragments for binding using target immobilized NMR screening (TINS). The ability to insert a broad array of membrane
proteins into nanodiscs, combined with the efficiency of TINS, demonstrates its potential as a generic approach for finding fragments target-
ing membrane proteins.Pantothenate Kinase 3 Regulation by Small Molecules
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Pantothenate kinase (PanK) catalyzes the rate-controlling step in coenzyme A (CoA) biosyn-
thesis. Biochemical analysis of site-directed mutants, reported by Leonardi et al., indicates
that pantothenate binds in a tunnel adjacent to the active site that is occupied by the panto-
thenate moiety of the acetyl-CoA regulator. A high-throughput screen for PanK3 inhibitors and
activators identified thiazolidinediones, sulfonylureas, and steroids as inhibitors and fatty
acyl-amides and tamoxifen as activators. The PanK3 activators and inhibitors either stimu-
lated or repressed CoA biosynthesis in cultured cells. The flexible acetyl-CoA regulatory
domain of PanK3 also binds the substrate, pantothenate, and small molecule inhibitors and
activators.A HAT Inhibitor Keeps Oral Cancer in Check
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Altered histone acetylation is associatedwith several diseases, including cancer. In the present
work, Arif et al. found that histones are hyperacetylated in oral cancer patient samples. Mech-
anistically, overexpression, as well as enhanced autoacetylation, of p300 induced by NPM1
and GAPDH proteins causes the hyperacetylation, which is nitric oxide (NO) signal dependent.
Inhibition of the histone acetyltransferase (HAT) activity of p300 by a water-soluble, small molecule inhibitor, Hydrazinocurcumin (CTK7A),
reduced the xenografted oral tumor growth in mice. This could be a potential antineoplastic therapeutic strategy, particularly against oral
cancer.0 Elsevier Ltd All rights reserved
